| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.078 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |